These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 7211723

  • 1. Postprandial exchange of apolipoprotein C-III between plasma lipoproteins.
    Barr SI, Kottke BA, Mao SJ.
    Am J Clin Nutr; 1981 Feb; 34(2):191-8. PubMed ID: 7211723
    [Abstract] [Full Text] [Related]

  • 2. Alimentary lipemia: plasma high-density lipoproteins and apolipoproteins CII and CIII in healthy subjects.
    Kashyap ML, Barnhart RL, Srivastava LS, Perisutti G, Allen C, Hogg E, Glueck CJ, Jackson RL.
    Am J Clin Nutr; 1983 Feb; 37(2):233-43. PubMed ID: 6823885
    [Abstract] [Full Text] [Related]

  • 3. Postprandial distribution of apolipoproteins C-II and C-III in normal subjects and patients with mild hypertriglyceridemia: comparison of meals containing corn oil and medium-chain triglyceride oil.
    Barr SI, Kottke BA, Mao SJ.
    Metabolism; 1985 Nov; 34(11):983-92. PubMed ID: 4058312
    [Abstract] [Full Text] [Related]

  • 4. Quantitation of human apolipoprotein C-III and its subspecie by radioimmunoassay and analytical isoelectric focusing: abnormal plasma triglyceride-rich lipoprotein apolipoprotein C-III subspecie concentrations in hypertriglyceridemia.
    Kashyap ML, Srivastava LS, Hynd BA, Gartside PS, Perisutti G.
    J Lipid Res; 1981 Jul; 22(5):800-10. PubMed ID: 7288286
    [Abstract] [Full Text] [Related]

  • 5. Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women.
    Wassef H, Bissonnette S, Dufour R, Davignon J, Faraj M.
    J Nutr; 2017 May; 147(5):754-762. PubMed ID: 28356429
    [Abstract] [Full Text] [Related]

  • 6. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J, Escolà-Gil JC, Rotllan N, Fiévet C, Vallez E, de la Torre C, Ribas V, Sloan JH, Blanco-Vaca F.
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [Abstract] [Full Text] [Related]

  • 7. Plasma apolipoprotein changes in the triglyceride-rich lipoprotein fraction of human subjects fed a fat-rich meal.
    Cohn JS, McNamara JR, Cohn SD, Ordovas JM, Schaefer EJ.
    J Lipid Res; 1988 Jul; 29(7):925-36. PubMed ID: 3411251
    [Abstract] [Full Text] [Related]

  • 8. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C, Tremblay M, Fredenrich A, Davignon J, Cohn JS.
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [Abstract] [Full Text] [Related]

  • 9. Abnormal activation of lipoprotein lipase by non-equilibrating apoC-II: further evidence for the presence of non-equilibrating pools of apolipoproteins C-II and C-III in plasma lipoproteins.
    Tornoci L, Scheraldi CA, Li X, Ide H, Goldberg IJ, Le NA.
    J Lipid Res; 1993 Oct; 34(10):1793-803. PubMed ID: 8245727
    [Abstract] [Full Text] [Related]

  • 10. Effects of dietary carbohydrate and fat on plasma lipoproteins and apolipoproteins C-II and C-III in healthy men.
    Kashyap ML, Barnhart RL, Srivastava LS, Perisutti G, Vink P, Allen C, Hogg E, Brady D, Glueck CJ, Jackson RL.
    J Lipid Res; 1982 Aug; 23(6):877-86. PubMed ID: 7130856
    [Abstract] [Full Text] [Related]

  • 11. Concentrations of apolipoproteins B, C-I, C-II, C-III, E and lipids in serum and serum lipoproteins of normal subjects during alimentary lipaemia.
    Annuzzi G, Holmquist L, Carlson LA.
    Scand J Clin Lab Invest; 1989 Feb; 49(1):73-81. PubMed ID: 2727620
    [Abstract] [Full Text] [Related]

  • 12. Postprandial plasma lipoprotein changes in human subjects of different ages.
    Cohn JS, McNamara JR, Cohn SD, Ordovas JM, Schaefer EJ.
    J Lipid Res; 1988 Apr; 29(4):469-79. PubMed ID: 3392464
    [Abstract] [Full Text] [Related]

  • 13. Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides.
    Dallinga-Thie GM, Berk-Planken II, Bootsma AH, Jansen H, Diabetes Atorvastatin Lipid intervention (DALI) Study Group.
    Diabetes Care; 2004 Jun; 27(6):1358-64. PubMed ID: 15161788
    [Abstract] [Full Text] [Related]

  • 14. Apolipoprotein C-III, hypertriglyceridemia and triglyceride-rich lipoproteins in uremia.
    Moberly JB, Attman PO, Samuelsson O, Johansson AC, Knight-Gibson C, Alaupovic P.
    Miner Electrolyte Metab; 1999 Jun; 25(4-6):258-62. PubMed ID: 10681649
    [Abstract] [Full Text] [Related]

  • 15. Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma.
    Björkegren J, Karpe F, Milne RW, Hamsten A.
    J Lipid Res; 1998 Jul; 39(7):1412-20. PubMed ID: 9684744
    [Abstract] [Full Text] [Related]

  • 16. Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans: in vivo evidence for a link between HDL apoC-III and apoA-I metabolism.
    Cohn JS, Batal R, Tremblay M, Jacques H, Veilleux L, Rodriguez C, Mamer O, Davignon J.
    J Lipid Res; 2003 Oct; 44(10):1976-83. PubMed ID: 12867543
    [Abstract] [Full Text] [Related]

  • 17. Independent regulation of plasma apolipoprotein C-II and C-III concentrations in very low density and high density lipoproteins: implications for the regulation of the catabolism of these lipoproteins.
    Le NA, Gibson JC, Ginsberg HN.
    J Lipid Res; 1988 May; 29(5):669-77. PubMed ID: 3411241
    [Abstract] [Full Text] [Related]

  • 18. Apolipoprotein C-III displacement of apolipoprotein E from VLDL: effect of particle size.
    Breyer ED, Le NA, Li X, Martinson D, Brown WV.
    J Lipid Res; 1999 Oct; 40(10):1875-82. PubMed ID: 10508207
    [Abstract] [Full Text] [Related]

  • 19. Fate of apolipoproteins C-1, C-iii, and E during lipolysis of human very low density lipoproteins in vitro.
    Tam SP, Dory L, Rubinstein D.
    J Lipid Res; 1981 May; 22(4):641-51. PubMed ID: 7276737
    [Abstract] [Full Text] [Related]

  • 20. Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients.
    Cassader M, Gambino R, Musso G, Depetris N, Mecca F, Cavallo-Perin P, Pacini G, Rizzetto M, Pagano G.
    Lipids; 2001 Oct; 36(10):1117-24. PubMed ID: 11768156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.